Details for Patent: 8,722,619
Which drugs does patent 8,722,619 protect, and when does it expire?
Patent 8,722,619 protects REZZAYO and is included in one NDA.
This patent has thirty-three patent family members in twenty-one countries.
Summary for Patent: 8,722,619
| Title: | Antifungal agents and uses thereof |
| Abstract: | The invention features echinocandin class compounds. The compounds can be useful for the treatment of fungal infections. |
| Inventor(s): | Kenneth Duke James, JR., Christopher Patrick Laudeman |
| Assignee: | NAPP PHARMACEUTICAL GROUP Ltd |
| Application Number: | US13/886,972 |
|
Patent Claim Types: see list of patent claims | Use; Composition; Delivery; Dosage form; |
Drugs Protected by US Patent 8,722,619
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mundipharma | REZZAYO | rezafungin acetate | POWDER;INTRAVENOUS | 217417-001 | Mar 22, 2023 | RX | Yes | Yes | 8,722,619 | ⤷ Start Trial | Y | Y | TREATMENT OF CANDIDEMIA AND INVASIVE CANDIDIASIS WITH REZAFUNGIN BY INTRAVENOUS ADMINISTRATION | ⤷ Start Trial | ||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 8,722,619
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| European Patent Office | 2680873 | ⤷ Start Trial | 301280 | Netherlands | ⤷ Start Trial |
| European Patent Office | 2680873 | ⤷ Start Trial | CA 2024 00025 | Denmark | ⤷ Start Trial |
| European Patent Office | 2680873 | ⤷ Start Trial | PA2024520 | Lithuania | ⤷ Start Trial |
| European Patent Office | 2680873 | ⤷ Start Trial | LUC00351 | Luxembourg | ⤷ Start Trial |
| European Patent Office | 2680873 | ⤷ Start Trial | 2024C/527 | Belgium | ⤷ Start Trial |
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
